News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Maas BiolAB, LLC Decreases Holdings in NeuroVive Pharmaceutical AB


9/21/2010 9:54:25 AM

ALBUQUERQUE, N.M.--(BUSINESS WIRE)--Maas Biolab LLC, the largest shareholder of NeuroVive Pharmaceutical AB of Lund, Sweden, is reducing its holdings by up to 2,207,304 shares. The NeuroVive shares will be distributed to up to 38 of its Swedish, American and international members that have elected to participate. The two-year lock-up period for distribution or sale of NeuroVive shares agreed to by Maas Biolab ends 3 October 2010, allowing this distribution.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES